(Q48331275)

10 February 2018

title

Fatigue in multiple sclerosis: interrelations between fatigue complaints, cerebral MRI abnormalities and neurological disability. (English)

1 reference

10 February 2018

0 references

van der Werf SP

1

1 reference

10 February 2018

Jongen PJ

2

1 reference

10 February 2018

Lycklama à Nijeholt GJ

3

1 reference

10 February 2018

Barkhof F

4

1 reference

10 February 2018

Hommes OR

5

1 reference

10 February 2018

Bleijenberg G

6

1 reference

10 February 2018

publication date

1 October 1998

1 reference

10 February 2018

Journal of the Neurological Sciences

published in

1 reference

10 February 2018

volume

160

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

page(s)

164-170

1 reference

10 February 2018

A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis. The Canadian MS Research Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900251-2

Amantadine treatment of fatigue associated with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900251-2

Brain magnetic resonance imaging correlates of cognitive impairment in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900251-2

Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900251-2

White matter lesions and cognitive deficits: relevance of lesion pattern?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900251-2

Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900251-2

Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900251-2

A brain MRI study of different types of chronic-progressive multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900251-2

Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900251-2

The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900251-2

Longitudinal MRI in multiple sclerosis: correlation between disability and lesion burden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900251-2

The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900251-2

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900251-2

Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900251-2

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900251-2

An electrophysiological study of the mechanism of fatigue in multiple sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900251-2

Correlation between magnetic resonance imaging and clinical parameters in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900251-2

The measurement of fatigue: A new instrument

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900251-2

Psychosocial correlates of fatigue in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900251-2

A neurologic rating scale (NRS) for use in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900251-2

Dimensional assessment of chronic fatigue syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900251-2

The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900251-2

A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900251-2

Side effect profile of interferon beta-1b in MS: results of an open label trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900251-2

Fatigue in MS is associated with specific clinical features.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900251-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(98)00251-2

1 reference

10 February 2018

PubMed ID

9849800

1 reference

10 February 2018